Skip to main content
Menu
search
0
CartClose Cart

Company news

news icon

Stay ahead with Sphere Fluidics

Join our community of forward-thinking scientists and stay informed with the latest breakthroughs, product launches, and exclusive offers. By subscribing to our newsletter, you'll be the first to know about innovations that can transform your lab.
Sphere Fluidics awarded gold accreditation by Investors in People
Sphere Fluidics awarded gold accreditation by Investors in PeopleNews

Sphere Fluidics awarded gold accreditation by Investors in People

Cambridge, UK, 14 June, 2024: Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for…
June 14, 2024
Sphere Fluidics Named Life Science Company of the Year at Cambridge Independent Science and Technology Awards 2024
Sphere Fluidics Named Life Science Company of the Year at Cambridge Independent Science and Technology Awards 2024News

Sphere Fluidics Named Life Science Company of the Year at Cambridge Independent Science and Technology Awards 2024

Celebrating Excellence in Life Sciences We're thrilled to announce that Sphere Fluidics has been awarded…
June 11, 2024
Sphere Fluidics launches Cyto-Cellect®PLUS to accelerate cell line development workflows
Sphere Fluidics Cyto-CellectPLUS
Sphere Fluidics launches Cyto-Cellect®PLUS to accelerate cell line development workflowsNews

Sphere Fluidics launches Cyto-Cellect®PLUS to accelerate cell line development workflows

Cambridge, UK, 04 June, 2024: Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for…
June 4, 2024
Sphere Fluidics appoints Curtis Nicholson as Director of Sales, EMEA, to support accelerated growth in key markets
Curtis Nicholson -Director of Sales, EMEA, to support accelerated growth in key markets
Sphere Fluidics appoints Curtis Nicholson as Director of Sales, EMEA, to support accelerated growth in key marketsNews

Sphere Fluidics appoints Curtis Nicholson as Director of Sales, EMEA, to support accelerated growth in key markets

Cambridge, UK, 23 May 2024: Curtis’ appointment will strengthen the Company’s market position in these…
May 23, 2024
Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer
Sphere fluidics appoints Dale Levitzke
Sphere Fluidics appoints Dale Levitzke as Chief Executive OfficerNews

Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer

Dale Levitzke joins as Dr. Frank F. Craig, current CEO and co-founder, announces his retirement…
April 30, 2024
Sphere Fluidics appoints Edward Rayner as Non-Executive Director
Ed Rayner - , Non-Executive Director
Sphere Fluidics appoints Edward Rayner as Non-Executive DirectorNews

Sphere Fluidics appoints Edward Rayner as Non-Executive Director

Ed Rayner joins Sphere Fluidics as new board member to strengthen the Company’s strategic vision…
April 17, 2024
Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing
Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and MarketingNews

Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing

Appointment to senior leadership team strengthens the Company’s plans for continued growth to advance its…
December 14, 2023
Sphere Fluidics’ Cyto-Mine® system selected by FairJourney Biologics to advance cell line development workflows
Sphere Fluidics’ Cyto-Mine® system selected by FairJourney Biologics to advance cell line development workflowsNews

Sphere Fluidics’ Cyto-Mine® system selected by FairJourney Biologics to advance cell line development workflows

Investment to expand cell line development capabilities and accelerate customer workflows, as part of its diverse…
October 3, 2023
Sphere Fluidics expands Cyto-Mine capabilities to meet cGMP requirements for drug manufacture workflows
Cyto-mine product
Sphere Fluidics expands Cyto-Mine capabilities to meet cGMP requirements for drug manufacture workflowsNews

Sphere Fluidics expands Cyto-Mine capabilities to meet cGMP requirements for drug manufacture workflows

Latest software updates support FDA 21 CFR Part 11 compliance and a full IQ/OQ package…
July 5, 2023
Sphere Fluidics’ Pico-Mine platform chosen by Biosyntia to accelerate synthetic biology and metabolic workflows
Sphere Fluidics’ Pico-Mine platform chosen by Biosyntia to accelerate synthetic biology and metabolic workflowsNews

Sphere Fluidics’ Pico-Mine platform chosen by Biosyntia to accelerate synthetic biology and metabolic workflows

Platform selected to accelerate precision fermentation workflows, to support more sustainable and cost-effective manufacturing for…
June 20, 2023
Sphere Fluidics updates brand identity to align with ambitious, global commercial growth strategy
sphere fluidics logo
Sphere Fluidics updates brand identity to align with ambitious, global commercial growth strategyNews

Sphere Fluidics updates brand identity to align with ambitious, global commercial growth strategy

New branding reflects customer-centric approach and showcases pioneering, single cell analysis technology Rebrand follows a…
May 23, 2023
Kenneth Hitchner Appointed as Chairman
Ken Hitchner headshot
Kenneth Hitchner Appointed as ChairmanNews

Kenneth Hitchner Appointed as Chairman

We're thrilled to announce the appointment of Kenneth Hitchner, BA MBA, as the new Chairman…
May 2, 2023
Sphere Fluidics begins work with partners on 3DSecret program to investigate mechanisms of metastasis in cancer.
Sphere Fluidics begins work with partners on 3DSecret program to investigate mechanisms of metastasis in cancer.News

Sphere Fluidics begins work with partners on 3DSecret program to investigate mechanisms of metastasis in cancer.

3DSecret funded by European Innovation Council’s Pathfinder Open 2022, established under the EU Horizon Europe…
April 24, 2023
Sphere Fluidics appoints Richard Hammond as Chief Technical Officer
Richard Hammond headshot
Sphere Fluidics appoints Richard Hammond as Chief Technical OfficerNews

Sphere Fluidics appoints Richard Hammond as Chief Technical Officer

Key appointment forms part of ongoing plans to strengthen senior leadership team and support expansion…
December 13, 2022
Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK
Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UKNews

Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK

Investment in purpose-built facilities supports ongoing recruitment and growth in new product development activities. First…
October 24, 2022
Sphere Fluidics strengthens commercial team with three new senior hires
sphere fluidics logo
Sphere Fluidics strengthens commercial team with three new senior hiresNews

Sphere Fluidics strengthens commercial team with three new senior hires

Evelyn Stevenson joins as Director of Product Management, Ravi Girdhar as Director of Sales in…
May 10, 2022
Antibody Engineering and Therapeutics 2019
Antibody Engineering & Therapeutics logo
Antibody Engineering and Therapeutics 2019News

Antibody Engineering and Therapeutics 2019

Date: December 9th - 13th, 2019 Location: Marriott Marquis San Diego, San Diego, CA
December 9, 2019
Bio-Europe
Bio-Europe Logo
Bio-EuropeNews

Bio-Europe

Date: November 11th - 13th, 2019 Location: Hamburg, Germany
November 11, 2019
Drug Discovery 2019
Drug discovery 2019 logo
Drug Discovery 2019News

Drug Discovery 2019

Date: November 5th - 6th, 2019 Location: ACC, Liverpool
November 5, 2019
events icon

View upcoming events we will be attending

Don't miss out on the chance to meet us in person at one of the many events we will be attending this year. Check out our list of upcoming events.

View events